Mentions in press and media 11
| Date | Title | Description |
| Sign up to see | Sign up to see | Sign up to see |
| Jun 6, 2019 | Third Rock raises $770 million in new funding round | Creating life sciences firms may be risky, but the appetite of investors shows no sign of waning. Third Rock Ventures, the Boston venture capital firm, said Thursday that it has raised $770 million from investors for its fifth and latest fu... |
| Jun 6, 2019 | Third Rock Ventures Raises $770 Million Fund V | BOSTON--(BUSINESS WIRE)--Third Rock Ventures, LLC announced today the closing of Third Rock Ventures V, LP, raising $770 million in an oversubscribed fund. With Fund V, the firm will continue to execute on its strategy of discovering, launc... |
| Jun 6, 2019 | Third Rock raises $770M to build and grow more biotechs W h i t e p a p e r Weighing the Costs: | Third Rock Ventures has raised $770 million for its fifth fund. The investment vehicle, the largest ever raised by Third Rock, will support investments in 10 to 12 companies. Sponsored by Agilent Technologies How would you like to win free ... |
| May 3, 2018 | Third Rock Ventures Launches Casma Therapeutics with $58.5 Million Investment | CAMBRIDGE, Mass.--(BUSINESS WIRE)--Casma Therapeutics, Inc., a biotechnology company harnessing the natural cellular process of autophagy to design powerful new medicines, launched today with $58.5 million in Series A funding from Third Roc... |
| Mar 30, 2017 | Third Rock Ventures Launches Tango Therapeutics with $55 Million Series A Investment | CAMBRIDGE, Mass.--(BUSINESS WIRE)--Third Rock Ventures, LLC today announced the launch of Tango Therapeutics, a new cancer therapeutics company discovering and developing novel medicines designed to target cancer vulnerabilities beyond muta... |
| Dec 14, 2016 | Third Rock Ventures Launches Goldfinch Bio with $55 Million Series A Investment | CAMBRIDGE, Mass.--(BUSINESS WIRE)--Third Rock Ventures, LLC today announced the launch of Goldfinch Bio, a company focused on discovering and developing precision therapies for patients with kidney disease. Goldfinch was launched with $55 m... |
| Oct 31, 2016 | Third Rock Ventures Raises $616 Million Fund IV | BOSTON--(BUSINESS WIRE)--Third Rock Ventures, LLC announced today the closing of Third Rock Ventures IV, LP, raising $616 million in an oversubscribed fund. With Fund IV, the firm will continue to execute on its strategy of creating innovat... |
| Sep 14, 2016 | Third Rock Ventures Launches Relay Therapeutics with $57 Million Series A Financing | CAMBRIDGE, Mass.--(BUSINESS WIRE)--Third Rock Ventures, LLC today announced the formation of Relay Therapeutics with $57 million in Series A financing, including participation from an affiliate of D. E. Shaw Research, LLC. Relay Therapeutic... |
| Jul 25, 2016 | Myanmar-centric PE Golden Rock Capital raises $20 m for its $100m fund | Premium Myanmar-centric Private Equity firm Golden Rock Capital, has raised $20 million, towards if $100 million fund, that will focus on consumer and service sectors, Marvin Yeo, founding partner of Golden Rock Capital, said in an interact... |
Show more